SCHEMBL18923967

SCHEMBL18923967

CN(C=O)C1(N)CCCC1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.32
ADH1C P00326 1/20 0.30
ADH1A P07327 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4118119 0.90
SCHEMBL8083763 0.69
Hydrochloric Acid SCHEMBL23040945 0.69
SCHEMBL3469334 0.68 ADH1C (0.33) TSHRADH1CADH1A
SCHEMBL10789268 0.67 TSHR (0.31) TSHR
SCHEMBL8083808 0.67 SLC6A2 (0.31) TSHR
SCHEMBL304273 0.67 SLC6A2 (0.31) TSHR
SCHEMBL20054259 0.64
SCHEMBL8087143 0.64
SCHEMBL26705601 0.63 ADH1C (0.33) TSHRADH1CADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9669031-B2 MNK inhibitors and methods related thereto EFFECTOR THERAPEUTICS, INC. (US) 2017-06-06 US disclosed